Home
Conditions
Splenic Diseases

Clinical trial condition

Splenic Diseases

Explore clinical trials studying Splenic Diseases. Study availability and eligibility vary by location and protocol.

16 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Splenic Diseases trial results

Recruiting

Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients

NCT06730126

Conditions: Autoimmune Diseases, Autoimmune Lymphoproliferative Syndrome, Autoimmune Lymphoproliferative Syndrome, Type IA, +9 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Recruiting

Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection

NCT07462091

Conditions: Cirrhosis, Digestive System Diseases, Fibrosis, +8 more
Locations: Clinical Medical College of Yangzhou University Yangzhou, Jiangsu, China

Clinical Medical College, Yangzhou University Yangzhou, Jiangsu, China

View Trial Details

Recruiting

Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD

NCT07461532

Conditions: Cirrhosis, Digestive System Diseases, Fibrosis, +10 more
Locations: Clinical Medical College Yangzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Effect of Laparoscopic Splenectomy on Renal Function in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)

NCT07585773

Conditions: Cirrhosis, Digestive System Diseases, Fibrosis, +10 more
Locations: Clinical Medical College of Yangzhou University Yangzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Effect of Laparoscopic Splenectomy on Lipid Profiles in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)

NCT07588373

Conditions: Cirrhosis, Digestive System Diseases, Fibrosis, +10 more
Locations: Clinical Medical College of Yangzhou University Yangzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)

NCT07588334

Conditions: Cirrhosis, Liver, Digestive System Diseases, Fibrosis, +12 more
Locations: Clinical Medical College of Yangzhou University Yangzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Hematological Disorders in EHPVO Patients

NCT07108023

Conditions: Anemia, Anemia, Hemolytic, Antiphospholipid Syndrome, +21 more
Locations: Not specified

View Trial Details

Completed

Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study

NCT02145143

Conditions: Abnormalities, Multiple, Cardiovascular Abnormalities, Cardiovascular Diseases, +16 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

The Treatment of Hepatocirrhosis and Portal Hypertension

NCT02778425

Conditions: Blood Platelet Disorders, Cytopenia, Digestive System Diseases, +14 more
Locations: Department of Gastroenterology,Qilu Hospital,Shandong University Jinan, Shandong, China

View Trial Details

Completed

Transfemoral Versus Transradial Partial Splenic Artery Embolization in Patients With Hypersplenism

NCT05446116

Conditions: Hemic and Lymphatic Diseases, Hypersplenism, Lymphatic Diseases, +1 more
Locations: Faculty of medicine, Zagazig university Zagazig, Egypt

View Trial Details

Splenic Diseases

Splenic Diseases trial results

Related conditions